A nurse is planning to administer betamethasone to a gravid client. Which client is most likely to receive this prescription?
A client who is 16-weeks gestation and is experiencing vaginal bleeding and cramping.
A client who is 37-weeks gestation and whose cervix is 7 cm dilated, 100% effaced, and a -1 station.
A client who is 38-weeks gestation and whose amniotic membranes ruptured at home 24 hours ago.
A client who is 30-weeks gestation and is contracting regularly and exhibiting cervical change.
The Correct Answer is D
Choice A rationale
Betamethasone is a corticosteroid used to accelerate fetal lung maturation by stimulating the production of surfactant. It is not indicated for treating threatened abortion, which is characterized by vaginal bleeding and cramping before 20 weeks gestation. The primary goal in this scenario is to maintain the pregnancy, not to prepare for a preterm birth.
Choice B rationale
At 37 weeks gestation, the fetus is considered full term. At this point, the fetal lungs are mature, and the administration of betamethasone is unnecessary. The client is in active labor, and the primary focus is on monitoring the labor progress and preparing for a vaginal delivery.
Choice C rationale
Prolonged rupture of membranes at term (38 weeks gestation) increases the risk of infection. While betamethasone could be used for fetal lung maturity, it is not indicated at term. The primary intervention is to monitor for signs of infection and initiate labor to prevent ascending bacterial infection to the fetus.
Choice D rationale
Betamethasone is indicated for clients at risk for preterm delivery between 24 and 34 weeks gestation. The medication crosses the placenta to accelerate fetal lung maturity by inducing surfactant synthesis. This intervention reduces the incidence and severity of respiratory distress syndrome, a major complication of prematurity.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A rationale
The primary goal of magnesium sulfate therapy in preeclampsia is seizure prophylaxis, not solely blood pressure reduction. While a decrease in blood pressure is a beneficial effect, the client’s pressures remain elevated (normal range is 120/80 mm Hg). Discontinuing the infusion would remove the anticonvulsant effect, potentially increasing the risk of a seizure, which is a major complication of severe preeclampsia.
Choice B rationale
Decreasing the dosage of magnesium sulfate would reduce the therapeutic serum magnesium level. This could compromise the anticonvulsant effect needed to prevent eclamptic seizures. The current dosage should be maintained to achieve and sustain the target therapeutic range, which is typically 4.8 to 8.4 mg/dL.
Choice C rationale
The nurse should continue to monitor the client's vital signs and the effectiveness of the magnesium sulfate. The observed decrease in blood pressure from 146/90 to 141/86 mm Hg within a 10-minute interval suggests a positive therapeutic trend. This indicates the medication is having its intended effect of vasodilation. Continued monitoring is crucial to assess for further improvement or signs of toxicity.
Choice D rationale
Increasing the frequency of blood pressure checks is not the most appropriate primary action. While frequent monitoring is essential, the blood pressure values are showing a positive response. The current monitoring schedule is likely adequate. There is no immediate indication of a new complication or an acute deterioration that would warrant more frequent checks.
Correct Answer is D
Explanation
Choice A rationale
A decrease of 0.8 g/dL in hemoglobin over two days is a significant change, not a normal fluctuation. Normal daily fluctuations are typically less than 0.5 g/dL. This magnitude of change indicates a pathological process, such as blood loss or hemodilution, which requires further investigation to determine the underlying cause.
Choice B rationale
An improvement in fluid status, such as a decrease in hypervolemia, would typically lead to an increase in hemoglobin concentration due to a reduction in the diluting effect of excess plasma volume. A decrease in hemoglobin, as observed here, suggests either blood loss or worsening fluid retention, which dilutes the red blood cell count.
Choice C rationale
While a decrease in hemoglobin can be a sign of hemorrhage, it does not, in itself, directly indicate an increased risk for future hemorrhage. It indicates that blood loss has likely already occurred or that there is an underlying issue causing the decrease. The decrease is a result of a process, not a risk factor for a future event.
Choice D rationale
The decrease in hemoglobin from 11.2 g/dL to 10.4 g/dL over a short period indicates a worsening anemic state. Anemia is a condition characterized by a deficit of red blood cells or hemoglobin. This change suggests that the underlying cause, whether it is blood loss or a physiological process, is worsening and requires intervention.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
